Company: EDSA
Filing Date: 2025-07-25
Form Type: S-3
Source: 0001171843-25-004721
Chunk: 42

Company: Edesa Biotech, Inc.
Filing Date: 2025-07-25
Form: S-3
Chunk 42
---

 purchaser in the initial distribution of the securities, the registrant undertakes that in a primary offering of securities of the registrant  
 pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities 
 are offered or sold to such purchaser by means of any of the following communications, the registrant will be a seller to the purchaser        
 and will be considered to offer or sell such securities to such purchaser:                                                                     |

| (a) | Any preliminary prospectus or prospectus of the registrant relating to the offering required to be filed 
 pursuant to Rule 424;                                                                                    |

| (b) | Any free writing prospectus relating to the offering prepared by or on behalf of the registrant or used 
 or referred to by the registrant;                                                                       |

| (c) | The portion of any other free writing prospectus relating to the offering containing material information 
 about registrant or its securities provided by or on behalf of the registrant; and                        |

| (d) | Any other communication that is an offer in the offering made by a registrant to the purchaser. |

| (6) | That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s                          
 annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee 
 benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference           
 in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the       
 offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.                                     |

| (7) | Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to                                      
 directors, officers and controlling persons of the registrant pursuant to the forgoing provisions, or otherwise, the registrant has been     
 advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the      
 Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment         
 by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense      
 of any action, suit or proceeding) is asserted by such director